Get the app!
Back to Trades
Sell4

CoreWeave, Inc.

CRWV

Total Value
$8.1M
Net $8.1M sold
Sales
$8.1M
14 transactions

Company Information

Company Name
CoreWeave, Inc.
Ticker Symbol
CRWV
CIK
0001769628

Insider Information

Role
Chief Development Officer
Officer
Location
LIVINGSTON, NJ

Filing Details

Filing Date
Dec 4, 2025
Transaction Date
Dec 2, 2025
Accession Number
0001769628-25-000094
Form Type
4
Net Trading Amount
-$8.1M

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Dec 2, 2025Class A Common Stock102,835C
Dec 2, 2025Class A Common Stock25,000C
Dec 2, 2025Class A Common Stock3,000C
Dec 2, 2025Class A Common Stock1,000C
Dec 2, 2025Class A Common Stock1,000C
Dec 2, 2025Class A Common Stock25,000C
Dec 2, 2025Class A Common Stock8,335C
Dec 2, 2025Class A Common Stock69$76.23Sale$5.3K
Dec 2, 2025Class A Common Stock126$77.56Sale$9.8K
Dec 2, 2025Class A Common Stock147$78.40Sale$11.5K
Dec 2, 2025Class A Common Stock48$79.42Sale$3.8K
Dec 2, 2025Class A Common Stock42$80.50Sale$3.4K
Dec 2, 2025Class A Common Stock48$81.46Sale$3.9K
Dec 2, 2025Class A Common Stock20$82.24Sale$1.6K
Dec 2, 2025Class A Common Stock14,306$76.23Sale$1.1M
Dec 2, 2025Class A Common Stock25,818$77.56Sale$2.0M
Dec 2, 2025Class A Common Stock30,173$78.40Sale$2.4M
Dec 2, 2025Class A Common Stock9,947$79.42Sale$790.0K
Dec 2, 2025Class A Common Stock8,720$80.50Sale$701.9K
Dec 2, 2025Class A Common Stock9,781$81.46Sale$796.8K
Dec 2, 2025Class A Common Stock4,090$82.24Sale$336.4K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Dec 2, 2025Derivative102,835C
Dec 2, 2025Derivative25,000C
Dec 2, 2025Derivative3,000C
Dec 2, 2025Derivative1,000C
Dec 2, 2025Derivative1,000C
Dec 2, 2025Derivative25,000C
Dec 2, 2025Derivative8,335C

Footnotes

  1. (F1)Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
  2. (F2)The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee.
  3. (F3)The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager.
  4. (F4)The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.
  5. (F5)The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.
  6. (F6)The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.
  7. (F7)The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.
  8. (F8)The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
  9. (F9)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.98 to $76.97 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this filing.
  10. (F10)The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.
  11. (F11)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.98 to $77.97, inclusive.
  12. (F12)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.98 to $78.97, inclusive.
  13. (F13)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.98 to $79.96, inclusive.
  14. (F14)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.99, inclusive.
  15. (F15)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.99, inclusive.
  16. (F16)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.02 to $82.78, inclusive.
  17. (F17)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.98 to $76.97, inclusive.
  18. (F18)The reported securities are directly held of record by the reporting person's minor child.
  19. (F19)For clarity, the reporting person and his spouse previously effected the following transfers: (i) 16,600 shares of the Issuer's Class B Common Stock were transferred by the reporting person to the Canis Major 2025 Family Trust LLC, and (ii) 20,000 shares of the Issuer's Class B Common Stock were transferred by the reporting person's spouse to the Canis Minor 2025 Family Trust LLC, in transactions exempt from reporting under Section 16 of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16a-13. The totals reported in Column 9 of Table II reflect ownership after such transfers and the other reportable transactions listed herein.
  20. (F20)The reported securities are directly held by the reporting person's spouse.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.